This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
  • Latest Dividend: 1.00
  • Latest Dividend Yield: 0.00%
  • Dividend Ex-Date: 11/10/10
  • Price Earnings Ratio: -48.3234
  • Price Earnings Comparisons:
    VRX Sector Avg. S&P 500
    -48.32 0.00 27.19
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    2.30% 10.41% 246.80%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 62.70 3.88 0.69
    Net Income 0.00 3.15 0.00
    EPS 0.00 1.55 0.00
  • Earnings for VRX:
    EBITDA 2.37B
    REVENUE 5.77B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.00 $n.a. $1.92 $4.63
Number of Analysts 2 0 2 2
High Estimate $1.20 $n.a. $2.21 $4.69
Low Estimate $0.81 $n.a. $1.62 $4.56
Prior Year $2.15 $1.74 $6.19 $1.92
Growth Rate (Year over Year) -53.26% n.a.% -69.06% 141.51%
VRX News

VRX Valeant Pharmaceuticals International Inc

Analysts Ratings for VRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 8 8 8
Moderate Buy 1 1 1 1
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET VRX ANALYST REPORT

Brokerage Partners

VRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs